Healix

Parenteral Antimicrobial Therapy Initiated in the Infectious Disease (ID) Physician Office: What and Why?

Authors:
Kimberly A. Couch, PharmD, MA, FIDSA, – Healix Infusion Therapy, Inc., Sugar Land, TX
Lucinda J. Van Anglen, PharmD, – Healix Infusion Therapy, Inc., Sugar Land, TX
Alfred E. Bacon III, MD – Infectious Disease Associates, P.A., Newark, DE

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound